Department of Health and Human Services Food and Drug Administration FDA ORPHAN DRUG DESIGNATION REQUEST FORM Form Approved OMB Control Number: 0910-0167 Expiration Date: January 31, 2027 See OMB.
Open form follow the instructions
Easily sign the form with your finger
Send filled & signed form or save
How to fill out the FDA 4035 online
The FDA 4035 form is essential for submitting requests for orphan drug designations. This guide will walk you through the process of filling out the form online, ensuring a clear understanding of each section and requirement.
Follow the steps to successfully complete the FDA 4035 form online.
- Click ‘Get Form’ button to obtain the form and open it for editing.
- Enter the date of request in the format mm/dd/yyyy. If you are amending a previous request, include the designation request number.
- Provide your contact information. Fill in the required fields, including your business name, primary contact details, and preferred email for FDA communications.
- If applicable, include information for a U.S. resident agent. This is required for foreign sponsors submitting the request.
- Complete the product information section, specifying if the product is a biologic, drug, or combination product. Fill in the generic/descriptive name and trade name.
- Identify the orphan disease or condition. Choose the applicable treatment or prevention category and provide specifics.
- Describe the disease or condition, the proposed drug usage, and the reasons for therapy necessity. Attach relevant documents as necessary.
- Provide the scientific rationale that supports the drug's efficacy for the specified condition. Include human and animal data if available.
- Indicate whether the same drug has been approved for the same use. If so, provide a hypothesis for clinical superiority.
- Execute self-certification regarding previous marketing applications for the same drug/disease before submitting.
- Estimate the affected population and document it to ensure it is under 200,000 persons. Attach all calculations used.
- Finally, review all entries for accuracy, then save your changes, and download, print, or share the completed form as needed.
Begin filling out the FDA 4035 form online today to ensure your request for orphan drug designation is submitted accurately.
Experience a faster way to fill out and sign forms on the web. Access the most extensive library of templates available.
Related content
May 23, 2024 — The Form FDA 4035 is designed to assist sponsors in providing the...
The PATH Study is an ongoing longitudinal cohort study on tobacco use behavior, attitudes...
Jun 18, 2019 — Pulmonary-Allergy Drugs Advisory Committee, FDA, Ad Hoc Member, 2014-2019...
Get answers to your most pressing questions about US Legal Forms API.
Is Paxlovid FDA approved now?
The Food and Drug Administration (FDA) gave the drug full approval in May 2023 for adults with mild-to-moderate COVID at high risk for severe disease, hospitalization, and death.
What drug is FDA approved for Covid-19 vaccine?
The updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine, both of which are authorized for emergency use for individuals 6 months through 11 years of age.
Is orphan drug designation a big deal?
The Orphan Drug Act was created to stimulate the development of drugs and biologics for rare diseases. Investigating products that have received orphan drug designation provide a greater understanding of rare disease drug development, as well as the repositioning business models of developers.
What COVID therapeutics are FDA approved?
If you are infected but being treated outside of the hospital, the FDA has approved Paxlovid (nirmatrelvir tablets and tablets, co-packaged for oral use) to treat COVID-19 in certain adults. For certain adult and pediatric patients with COVID-19, the FDA has approved Veklury (remdesivir).
Is orphan drug designation the same as FDA approval?
Orphan drug designation is a separate process from seeking approval or licensing. Drugs for rare diseases go through the same rigorous scientific review process as any other drug for approval or licensing. See the Orphan Drug Designations and Approvals database for more information.
Which is better, Paxlovid or Remdesivir?
Paxlovid has an average rating of 7.2 out of 10 from a total of 520 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 21% reported a negative effect. Remdesivir has an average rating of 5.1 out of 10 from a total of 38 ratings on Drugs.com.
Has remdesivir been FDA approved?
Remdesivir has been approved by the United States Food and Drug Administration (FDA) on April 25, 2022 as the first COVID-19 treatment for young children, specifically ≥28-days-old children, weighing ≥3 kilograms, who are either hospitalized or non-hospitalized, showing a high risk for progression to severe COVID-19 ( ...
What qualifies for the orphan drug designation?
Orphan Drug Act By definition, a disease or condition is classified as “rare” if it affects fewer than 200,000 people total in the United States, or if the cost of developing a drug and making it available in the United States for such diseases or conditions will exceed any potential profits from its sale.
Use professional pre-built templates to fill in and sign documents online faster. Get access to thousands of forms.
If you believe that this page should be taken down, please follow our DMCA take down process here.